Inhibition of advanced glycation end products (AGEs): An implicit goal in clinical medicine for the treatment of diabetic nephropathy?

Diabetes Research and Clinical Practice

Volumn 82, Issue SUPPL. 1, 2008, Pages

  Miyata, Toshio ^a   Dan, Takashi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Advanced glycation; Blood pressure; Chronic hypoxia; Oxidative stress; Renin angiotensin system

Indexed keywords

2 ISOPROPYLIDENEHYDRAZONO 4 OXO 5 THIAZOLIDINYLACETANILIDE; ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDIABETIC AGENT; ATENOLOL; CALCIUM CHANNEL BLOCKING AGENT; COBALT; ERYTHROPOIETIN; GLUCOSE; GLUCOSE TRANSPORTER; HEME OXYGENASE 1; HYPOXIA INDUCIBLE FACTOR 1; INSULIN; IRON; NIFEDIPINE; OLMESARTAN; PENTOSIDINE; PIOGLITAZONE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PYRIDOXAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TM 2002; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN; UNCLASSIFIED DRUG; VASCULOTROPIN; VON HIPPEL LINDAU PROTEIN;

ARTICLE; BLOOD PRESSURE; CALORIC RESTRICTION; DIABETIC NEPHROPATHY; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG INHIBITION; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; METABOLIC SYNDROME X; MONOTHERAPY; NONHUMAN; OBESITY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RENAL PROTECTION;

ANIMALS; CALORIC RESTRICTION; COBALT; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXIDATIVE STRESS; RATS; TREATMENT OUTCOME;

EID: 55249115971     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.09.012     Document Type: Article

References (21)

1. Nangaku M., Miyata T., Sad T., Mizuno M., Inagi R., Ueda Y., et al. Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model. J Am Soc Nephrol 14 (2003) 1212-1222
2. Nangaku M., Izuhara Y., Usuda N., Inagi R., Shibata T., Sugiyama S., et al. In a type 2 diabetic nephropathy rat model, the improvement of obesity by a low calorie diet reduces oxidative/carbonyl stress and prevents diabetic nephropathy. Nephrol Dial Transplant 20 (2005) 2661-2669
3. Izuhara Y., Nangaku M., Inagi R., Tominaga N., Aizawa T., Kurokawa K., et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16 (2005) 3631-3641
4. Wolf G., and Ritz E. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications. Kidney Int. 67 (2005) 799-812
5. Miyata T., Nangaku M., Suzuki D., Uragami K., Inagi R., Sakai H., et al. A mesangium-predominant gene, megsin, is a new serpin up-regulated in IgA nephropathy. J Clin Invest 102 (1998) 828-836
6. Miyata T., Inagi R., Nangaku M., Imasawa T., Sato M., Izuhara Y., et al. Overexpression of the serpin megsin induces progressive mesangial cell proliferation and expansion. J Clin Invest 109 (2002) 585-593
7. Inagi R., Yamamoto Y., Nangaku M., Usuda N., Okamoto H., Kurokawa K., et al. A severe diabetic nephropathy model with early development of nodular-like lesions induced by megsin overexpression in RAGE/iNOS transgenic mice. Diabetes 55 (2006) 356-366
8. The Epidemiology of Diabetes Interventions and Complications (EDIC) study. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy. JAMA 290 (2003) 2159-2167
9. Sarafidis P.A., and Ruilope L.M. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am. J. Nephrol. 26 (2006) 232-234
10. Pistrosch F., Herbrig K., Kindel B., Passauer J., Fischer S., and Gross P. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients. Diabetes 54 (2005) 2206-2211
11. Ohtomo S., Izuhara Y., Takizawa S., Yamada N., Kakuta T., van Ypersele de Strihou C., et al. Thiazolidinediones protects the kidney better than insulin in an obese, hypertensive type 2 diabetes rat model. Kidney Int. 72 (2007) 1512-1519
12. Ohtomo S., Nangaku M., Izuhara Y., Takizawa S., van Ypersele de Strihou C., and Miyata T. Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model. Nephrol Dial Transplant 23 (2007) 1166-1172
13. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J. Am. Soc. Nephrol. 17 (2006) 17-25
14. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5 (2004) 343-354
15. Salnikow K., Donald S.P., Bruick R.K., Zhitkovich A., Phang J.M., and Kasprzak K.S. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279 (2004) 40337-40344
16. Miyata T., van Ypersele de Strihou C., Ueda Y., Ichimori K., Inagi R., Izuhara Y., et al. Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms. J. Am. Soc. Nephrol. 13 (2002) 2478-2487
17. Forbes J.M., Cooper M.E., Thallas V., Burns W.C., Thomas M.C., Brammar G.C., et al. Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy. Diabetes 51 (2002) 3274-3282
18. Tsujita K., Shimomura H., Kawano H., Hokamaki J., Fukuda M., Yamashita T., et al. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction. Am. J. Cardiol. 94 (2004) 481-484
19. Izuhara Y., Nangaku M., Takizawa S., Takahashi S., Shao J., Oishi H., et al. A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models. Nephrol Dial Transplant 23 (2008) 497-509
20. Takizawa S., Izuhara Y., Kitao Y., Hori O., Ogawa S., Morita Y., et al. A novel inhibitor of advanced glycation and endoplasmic reticulum stress reduces infarct volume in rat focal cerebral ischemia. Brain Res. 1183 (2007) 124-137
21. Figarola J.L., Scott S., Loera S., Tessler C., Chu P., Weiss L., et al. LR-90 a new advanced glycation endproduct inhibitor prevents progression of diabetic nephropathy in streptozotocin-diabetic rats. Diabetologia 46 (2006) 1140-1152